Thymalin
Early humanThymus-derived polypeptide complex / immune 'bioregulator' (not a single defined molecule) · Also known as Thymalinum, thymus peptide bioregulator, Khavinson thymic peptide complex, thymalin (calf-thymus extract)
Overview
Thymalin is a polypeptide complex extracted from the thymus gland of young calves, developed in the USSR in the 1970s and used in Russia since the 1980s as an immune modulator. It is not a single defined peptide but a mixture of short peptides marketed as a 'bioregulator' that restores T-lymphocyte differentiation and corrects age-related immune decline. Its most striking claim comes from a long-term study by the St. Petersburg (Khavinson/Morozov) group, in which elderly patients given thymalin (alone or with the pineal peptide Epithalamin) over 6-8 years showed large reductions in mortality. These results, however, have not been replicated in independent Western randomized trials, originate almost entirely from a single research school, and are structured in ways outside-reviewers find difficult to audit by modern regulatory standards. As a calf-tissue-derived mixture lacking large independent trials, every benefit claim should be read with caution. It is not FDA-approved.
Commonly Reported Uses
These are uses commonly discussed or marketed by users and vendors — not a list of proven or approved benefits, and not a recommendation.
- Immune restoration and age-related immune decline (marketed claim; based on unreplicated single-school human trials)
- Longevity / reduced mortality in aging (marketed claim; striking Russian trial results, not independently replicated)
- General recovery and resistance to infection (marketed claim; not established in independent trials)
What to Track
Data points you and your clinician might monitor. For observation only — not a diagnostic protocol.
- Labs — white-cell count and lymphocyte subsets (e.g., CD4/CD8) if a clinician is monitoring immune status
- Labs — hs-CRP and IL-6 for a general inflammation/recovery signal
- Subjective — frequency/severity of infections and energy over time
- WHOOP — recovery, HRV and sleep trends as a well-being signal
- Subjective — daily energy and recovery check-ins
Sources & References
Quick Reference
- Class
- Thymus-derived polypeptide complex / immune 'bioregulator' (not a single defined molecule)
- Evidence Level
- Early human
- Reported Uses
- 3 listed
- Tracking Metrics
- 5 suggested
- Citations
- 2 sources
Safety & legal notes
NOT FDA-approved for any human indication and not an approved drug in the US; it is a Russia-origin thymic-extract product, commonly sold 'research use only' outside that market. The headline survival/mortality data comes from a single research school and has not been replicated in independent, blinded Western trials, so it does not meet the evidence conventions Western regulators require. As an animal-tissue-derived mixture, it carries the usual sourcing/contamination uncertainties of biologically extracted products. Not a primary WADA doping target, but athletes should verify current rules. Long-term human safety outside the original studies is not established. Consult a licensed clinician.
Track your protocol in Peplens
Connect your InBody, Whoop, smart scale, and nutrition data. See your Overlay — all metrics, one clear read.
Get started free →